243 related articles for article (PubMed ID: 30621914)
1. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
Zhang Z; Shao L; Wang Y; Luo X
Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
[TBL] [Abstract][Full Text] [Related]
4. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.
Liang Z; Li S; Xu X; Xu X; Wang X; Wu J; Zhu Y; Hu Z; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cells; 2015; 38(2):130-7. PubMed ID: 25556372
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
9. CREPT promotes glioma cell proliferation and invasion by activating Wnt/β-catenin pathway and is a novel target of microRNA-596.
Wei M; Cao Y; Jia D; Zhao H; Zhang L
Biochimie; 2019 Jul; 162():116-124. PubMed ID: 30995540
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
Chen H; Luo Q; Li H
Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503.
Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G
Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017
[TBL] [Abstract][Full Text] [Related]
12. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
14. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
15. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
16. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
17. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
18. CREPT regulated by miR-138 promotes breast cancer progression.
Liang Z; Feng Q; Xu L; Li S; Zhou L
Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.
Liu Y; Xu X; Xu X; Li S; Liang Z; Hu Z; Wu J; Zhu Y; Jin X; Wang X; Lin Y; Chen H; Mao Y; Luo J; Zheng X; Xie L
Oncol Lett; 2017 Nov; 14(5):5121-5128. PubMed ID: 29142597
[TBL] [Abstract][Full Text] [Related]
20. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
